Random biopsies during surveillance colonoscopy increase dysplasia detection in patients with primary sclerosing cholangitis and ulcerative colitis

Journal of Crohn's and Colitis

Volumn 7, Issue 12, 2013, Pages 974-981

  Navaneethan, Udayakumar ^a   Kochhar, Gursimran ^a   Venkatesh, Preethi G K ^a   Bennett, Ana E ^a   Rizk, Maged ^a   Shen, Bo ^a   Kiran, Ravi P ^a  

^a LERNER RESEARCH INSTITUTE   (United States)

Author keywords

Colonoscopy; Dysplasia; Inflammatory bowel disease; Random biopsies; Ulcerative colitis

Indexed keywords

ADULT; AGED; ARTICLE; COLON BIOPSY; COLON DISEASE; COLON DYSPLASIA; COLON TUMOR; COLONOSCOPY; DYSPLASIA; FEMALE; HUMAN; MAJOR CLINICAL STUDY; MALE; PRIMARY SCLEROSING CHOLANGITIS; PRIORITY JOURNAL; PROCTOCOLECTOMY; ULCERATIVE COLITIS;

ADJUSTED ODDS RATIO; AOR; BMI; BODY MASS INDEX; CD; COLONOSCOPY; COLORECTAL CANCER; CRC; CROHN'S DISEASE; DYSPLASIA; HGD; HIGH GRADE DYSPLASIA; IBD; INFLAMMATORY BOWEL DISEASE; LGD; LOW GRADE DYSPLASIA; RANDOM BIOPSIES; UC; ULCERATIVE COLITIS;

ADULT; AGED; BIOPSY; CARCINOMA; CHOLANGITIS, SCLEROSING; COLITIS, ULCERATIVE; COLON; COLONIC NEOPLASMS; COLONOSCOPY; FEMALE; HUMANS; MALE; MIDDLE AGED; POPULATION SURVEILLANCE; RANDOM ALLOCATION; TIME FACTORS; YOUNG ADULT;

EID: 84887615341     PISSN: 18739946     EISSN: 18764479     Source Type: Journal    
DOI: 10.1016/j.crohns.2013.02.009     Document Type: Article

References (32)

1. Navaneethan U., Shen B. Hepatopancreatobiliary manifestations and complications associated with inflammatory bowel disease. Inflamm Bowel Dis Sep 2010, 16(9):1598-1619.
2. Olsson R., Danielsson A., Jarnerot G., Lindstrom E., Loof L., Rolny P., et al. Prevalence of primary sclerosing cholangitis in patients with ulcerative colitis. Gastroenterology 1991, 100:1319-1323.
3. Broome' U., Bergquist A. Primary sclerosing cholangitis, inflammatory bowel disease, and colon cancer. Semin Liver Dis 2006, 26:31-40.
4. Broomé U., Löfberg R., Veress B., Eriksson L.S. Primary sclerosing cholangitis and ulcerative colitis: evidence for increased neoplastic potential. Hepatology 1995, 22:1404-1408.
5. Kornfeld D., Ekbom A., Ihre T. Is there an excess risk for colorectal cancer in patients with ulcerative colitis and concomitant primary sclerosing cholangitis? A population based study. Gut 1997, 41:522-525.
6. Claessen M.M., Vleggaar F.P., Tytgat K.M., Siersema P.D., van Buuren H.R. High lifetime risk of cancer in primary sclerosing cholangitis. J Hepatol 2008, 50:158-164.
7. Brentnall T.A., Haggitt R.C., Rabinovitch P.S., Kimmey M.B., Bronner M.P., Levine D.S., et al. Risk and natural history of colonic neoplasia in patients with primary sclerosing cholangitis and ulcerative colitis. Gastroenterology 1996, 110:331-338.
8. Pekow J.R., Hetzel J.T., Rothe J.A., Hanauer S.B., Turner J.R., Hart J., et al. Outcome after surveillance of low-grade and indefinite dysplasia in patients with ulcerative colitis. Inflamm Bowel Dis 2009, 16:1352-1356.
9. Shetty K., Rybicki L., Brzezinski A., Carey W.D., Lashner B.A. The risk for cancer or dysplasia in ulcerative colitis patients with primary sclerosing cholangitis. Am J Gastroenterol 1999, 94:1643-1649.
10. Thackeray E.W., Charatcharoenwitthaya P., Elfaki D., Sinakos E., Lindor K.D. Colon neoplasms develop early in the course of inflammatory bowel disease and primary sclerosing cholangitis. Clin Gastroenterol Hepatol Jan 2011, 9(1):52-56.
11. Itzkowitz S.H., Present D.H. Consensus conference: Colorectal cancer screening and surveillance in inflammatory bowel disease. Inflamm Bowel Dis 2005, 11:314-321. Crohn's and Colitis Foundation of America Colon Cancer in IBD Study Group.
12. Navaneethan U., Kochhar G., Venkatesh P.G., Lewis B., Lashner B.A., Remzi F.H., et al. Duration and severity of primary sclerosing cholangitis is not associated with the risk of neoplastic changes in the colon in patients with ulcerative colitis. Gastrointest Endosc 2012, 75:1045-1054.
13. Rubin C.E., Haggitt R.C., Burmer G.C., Brentnall T.A., Stevens A.C., Levine D.S., et al. DNA aneuploidy in colonic biopsies predicts future development of dysplasia in ulcerative colitis. Gastroenterology 1992, 103:1611-1620.
14. den Broek FJ Van, Fockens P., Van eeden S., Reitsma J.B., Hardwick J.C., Stokkers P.C., et al. Endoscopic tri-modal imaging for surveillance in ulcerative colitis: randomized comparison of high resolution endoscopy and autofluorescence imaging for neoplasia detection; and evaluation of narrow band imaging for classification of lesions. Gut 2008, 57:1083-1089.
15. Itzkowitz S.H., Harpaz N. Diagnosis and management of dysplasia in patients with inflammatory bowel diseases. Gastroenterology 2004, 126:1634-1648.
16. Rutter M.D., Saunders B.P., Wilkinson K.H., Rumbles S., Schofield G., Kamm M.A., et al. Cancer surveillance in longstanding ulcerative colitis: endoscopic appearances help predict cancer risk. Gut 2004, 53:1813-1816.
17. den Broek FJ Van, Stokkers P.C., Reitsma J.B., et al. Random biopsies taken during colonoscopic surveillance of patients with longstanding ulcerative colitis: low yield and absence of clinical consequences. Am J Gastroenterol Mar 22 2011, [Epub ahead of print].
18. Fausa O., Schrumpf E., Elgjo K. Relationship of inflammatory bowel disease and primary sclerosing cholangitis. Semin Liver Dis 1991, 11:31-39.
19. Rex D.K., Johnson D.A., Anderson J.C., et al. American College of Gastroenterology guidelines for colorectal cancer screening 2009. Am J Gastroenterol 2009, 104:1613.
20. Riddell R.H., Goldman H., Ransohoff D.F., Appelman H.D., Fenoglio C.M., Haggitt R.C., et al. Dysplasia in inflammatory bowel disease: standardized classification with provisional clinical applications. Hum Pathol 1983, 14:931-968.
21. Rubin D.T., Rothe J.A., Hetzel J.T., Cohen R.D., Hanauer S.B. Are dysplasia and colorectal cancer endoscopically visible in patients with ulcerative colitis?. Gastrointest Endosc 2007, 65:998-1004.
22. Blonski W., Kundu R., Lewis J., Aberra F., Osterman M., Lichtenstein G.R. Is dysplasia visible during surveillance colonoscopy in patients with ulcerative colitis?. Scand J Gastroenterol 2008, 43:698-703.
23. Rutter M.D., Saunders B.P., Wilkinson K.H., Kamm M.A., Williams C.B., Forbes A. Most dysplasia in ulcerative colitis is visible at colonoscopy. Gastrointest Endosc 2004, 60:334-339.
24. Rutter M.D., Saunders B.P., Schofield G., Forbes A., Price A.B., Talbot I.C. Pancolonic indigo carmine dye spraying for the detection of dysplasia in ulcerative colitis. Gut 2004, 53:256-260.
25. Hurlstone D.P., Sanders D.S., Lobo A.J., McAlindon M.E., Cross S.S. Indigo carmine-assisted high-magnification chromoscopic colonoscopy for the detection and characterization of intraepithelial neoplasia in ulcerative colitis: a prospective evaluation. Endoscopy 2005, 37:1186-1192.
26. Bernstein C.N., Weinstein W.M., Levine D.S., Shanahan F. Physicians' perceptions of dysplasia and approaches to surveillance colonoscopy in ulcerative colitis. Am J Gastroenterol 1995, 90:2106-2114.
27. Eaden J.A., Ward B.A., Mayberry J.F. How gastroenterologists screen for colonic cancer in ulcerative colitis: an analysis of performance. Gastrointest Endosc 2000, 51:123-128.
28. van Rijn A.F., Fockens P., Siersema P.D., Oldenburg B. Adherence to surveillance guidelines for dysplasia and colorectal carcinoma in ulcerative and Crohn's colitis patients in the Netherlands. World J Gastroenterol 2009, 15:226-230.
29. Watanabe T., Ajioka Y., Matsumoto T., Tomotsugu N., Takebayashi T., Inoue E., et al. Target biopsy or step biopsy? Optimal surveillance for ulcerative colitis: a Japanese nationwide randomized controlled trial. J Gastroenterol Jan 2011, 46(Suppl. 1):11-16.
30. Marion J.F., Waye J.D., Present D.H., Israel Y., Bodian C., Harpaz N., et al. Chromoendoscopy-targeted biopsies are superior to standard colonoscopic surveillance for detecting dysplasia in inflammatory bowel disease patients: a prospective endoscopic trial. Am J Gastroenterol 2008, 103:2342-2349.
31. Kiesslich R., Fritsch J., Holtmann M., Koehler H.H., Stolte M., Kanzler S., et al. Methylene blue-aided chromoendoscopy for the detection of intraepithelial neoplasia and colon cancer in ulcerative colitis. Gastroenterology 2003, 124:880-888.
32. Navaneethan U., Venkatesh P.G., Mukewar S., Lashner B.A., Remzi F.H., McCullough A.J., et al. Progressive primary sclerosing cholangitis requiring liver transplantation is associated with reduced need for colectomy in patients with ulcerative colitis. Clin Gastroenterol Hepatol 2012, 10:540-546.